Checked.be
Active
BE 0743.615.658Private limited company
Baveda
Hunnebergstraat 16 ·3900 Pelt, Belgium· 6 yrs active
Sector: Veterinary services
(75000)
Conclusion
Baveda has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €17k and a net result of €-2k. Equity is shrinking by ~3.8% per year across the filed fiscal years. Its solvency ranks better than 50% of 1470 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €17k |
| Net result | €-2k |
| Better than sector | 50% |
| Active | 6 yrs |
Financial profile
64
/ 100
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Health
70
Profitability
0
Solvency
97
Growth
52
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
70
/ 100
Healthy
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€1k
estimate, not credit advice
Score history
86
2021
89
2022
63
2023
70
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 2.11 (≥ 1.5)
+10
Quick ratio
Quick ratio 2.11 (≥ 1.0)
+5
Leverage
Debt/equity 0.83 (< 1.0)
+10
Profitability
Negatieve ROE -14%
-10
Interest coverage
Interest coverage 9.3× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 25-06-2025 with the NBB · fiscal year 2024 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
Equity: declining trend of ~3.8%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 75, Veterinary activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 54.7% | 54.3% | |
| Net result | €-2k | €29k | |
| Equity | €17k | €94k | |
| Gross operating margin | €6k | €64k | |
| Total assets | €31k | €218k |
€5k
-8.6%
21-24
€-2k
-9.7%
21-24
€5k
-5.5%
21-24
€31k
-28.3%
21-24
€17k
-12.5%
21-24
€7k
-41.5%
21-24
€128
+24.9%
21-24
€14k
-41.2%
21-24
€6k
-6.5%
21-24
€8k
-54.1%
21-24
2.11
-23.9%
21-24
2.11
-23.9%
21-24
54.7%
+22.1%
21-24
0.83
-32.7%
21-24
-14.3%
-25.4%
21-24
-7.8%
-53.1%
21-24
9.26
+0.7%
21-24
Figures by fiscal year and ratios
Change versus the prior fiscal year, coloured by direction (green = favourable).
| Fiscal year | 2024 Δ | 2023 Δ | 2022 Δ | 2021 Δ |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | -8.6% | -59.8% | -4.8% | - |
| Net profit | -9.7% | - | +11.5% | - |
| Cash flow | -5.5% | -57.0% | +0.6% | - |
| Staff costs | - | - | - | - |
| Income taxes | +24.9% | -95.1% | -16.6% | - |
| Dividends | - | - | - | - |
| Total assets | -28.3% | -2.4% | +52.3% | - |
| Equity | -12.5% | -10.2% | +49.5% | - |
| Debt | -41.2% | +5.1% | +55.2% | - |
| of which ≤ 1y | -6.5% | -23.6% | +97.0% | - |
| of which > 1y | -54.1% | +22.2% | +37.7% | - |
| Working capital | -41.5% | +239.5% | -72.7% | - |
| Employees (FTE) | - | - | - | - |
Ratios (computed)
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Current ratio | 2.11 | 2.77 | 1.40 | 3.87 |
| Quick ratio | 2.11 | 2.77 | 1.40 | 3.87 |
| Working capital ratio | 21.7% | 26.5% | 7.6% | 42.5% |
| Solvency | 54.7% | 44.8% | 48.7% | 49.6% |
| Debt / equity | 0.83 | 1.23 | 1.05 | 1.01 |
| Long-term debt ratio | 0.47 | 0.90 | 0.66 | 0.72 |
| Interest coverage | 9.26 | 9.20 | 21.20 | 16.74 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | -7.8% | -5.1% | 16.1% | 22.0% |
| ROE | -14.3% | -11.4% | 33.1% | 44.4% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2024
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €31k | €43k | €44k | €29k |
| Fixed assets | 21/28 | €18k | €25k | €32k | €12k |
| Formation expenses | 20 | - | - | - | €0 |
| Intangible fixed assets | 21 | €5k | €6k | €7k | €8k |
| Tangible fixed assets | 22/27 | €13k | €19k | €25k | €4k |
| Current assets | 29/58 | €13k | €18k | €12k | €17k |
| Amounts receivable within one year | 40/41 | €10k | €10k | €5k | €227 |
| Cash & bank | 54/58 | €2k | €7k | €6k | €16k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €31k | €43k | €44k | €29k |
| Equity | 10/15 | €17k | €19k | €22k | €14k |
| Contributions / capital | 10/11 | €3k | €3k | €3k | €3k |
| Reserves | 13 | €19k | €19k | €19k | €11k |
| Accumulated profits (losses) | 14 | €-5k | €-2k | - | - |
| Amounts payable | 17/49 | €14k | €24k | €23k | €15k |
| Amounts payable after one year | 17 | €8k | €17k | €14k | €10k |
| Amounts payable within one year | 42/48 | €6k | €6k | €8k | €4k |
| Trade debts payable within one year | 44 | €59 | €85 | €914 | €921 |
| Income statement | |||||
| Gross operating margin | 9900 | €6k | €6k | €14k | €15k |
| Operating result | 9901 | €-2k | €-1k | €10k | €10k |
| Financial income | 75 | €183 | €0 | €149 | - |
| Financial charges | 65 | €557 | €613 | €662 | €881 |
| Result before taxes | 9903 | €-2k | €-2k | €9k | €9k |
| Income taxes | 67/77 | €128 | €102 | €2k | €2k |
| Net result for the period | 9904 | €-2k | €-2k | €7k | €6k |
| Result to be appropriated | 9905 | €-2k | €-2k | €7k | €6k |
Legal Structure
| NACE primary | Veterinary services(75000) |
| Legal form | Private limited company(610) |
| Incorporation | 13-02-2020 |
| Status | Active |
| Postal code | 3900 |
Establishment units
Baveda
since 20202.299.123.395
Real-estate footprint
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72502E0589/00Z012 | Flanders | 767 m² | 1 · 123 m² | 8.6 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €-2k
Net result drops to €-2k, the lowest in the series.
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
26-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2021net €7k ▲11.5%
Net result €7k, the highest in the series.
20-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
21-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Veterinary services75000
Names & trade names
| Legal nameNL | Baveda |
Similar companies
Dierenarts Leen Verschraegen
BE 1008.975.390 · Maldegem
Dierenarts Vétérinaire Soline Bernaerts
BE 1020.381.305 · Dilbeek
VETANIMA
BE 0779.316.014 · Gembloux
SERVICES ELEVAGE SRL
BE 0738.984.897 · Beaumont
SITOVETO
BE 0766.712.348 · Braine-le-Château